MicroVision, Inc.
31.12.2021 22:08:21 CET | ACCESS Newswire | Press release
- Virtual Private Scheduled Meetings With Potential Customers, Partners, and Investment Community
- Press Conference Webcast to Be Held on January 5, 2022 at 11:00am PT
- Investment Community Webcast to Be Held on January 5, 2022 at 2:00pm PT
REDMOND, WA / ACCESSWIRE / December 31, 2021 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, has announced that the Company will shift to a fully virtual presence for the 2022 Consumer Electronics Show (CES®).
MicroVision's virtual presence next week will include virtual private scheduled meetings with potential customers, partners, and the investment community, a press conference webcast on January 5, 2022 at 11:00am PT, and an investment community webcast on January 5, 2022 at 2:00pm PT.
"Due to the quickly evolving COVID-19 infection rates and uncertainty around the Omicron variant, MicroVision will have a virtual presence in CES® 2022 rather than participating in person," said Sumit Sharma, MicroVision's Chief Executive Officer. "Following the initial public demonstration of our automotive sensor technology in September at the IAA Mobility Show in Munich, we look forward to virtually connecting and interacting with potential customers, partners, investment community, and media to demonstrate our technology and discuss our strategy. We look forward to participating in-person at CES® 2023."
To schedule a virtual appointment and private technology demonstration with MicroVision or learn more about MicroVision's exciting technology, customers, investment community, and media should contact Jeff Christensen at MVIS@darrowir.com.
Press Conference Webcast on January 5, 2022 at 11:00am PT
The Company will host a webcast consisting of prepared remarks by Sumit Sharma, Chief Executive Officer, along with a slide presentation and a question-and-answer session at 11:00am PT (2:00pm ET) on Wednesday, January 5, 2022 to demonstrate the Company's automotive sensor technology. The media may pose questions for management during this live webcast on January 5, 2022.
The live webcast and slide presentation, once posted, can be accessed on the Company's Investors webpage under the Events & Presentations tab at https://ir.microvision.com/events-presentations. The webcast will be archived on the website for future viewing.
Investment Community Informal Webcast on January 5, 2022 at 2:00pm PT
The Company will host a webcast consisting of prepared remarks by Sumit Sharma, Chief Executive Officer, and Anubhav Verma, Chief Financial Officer, along with a slide presentation and a question-and-answer session at 2:00pm PT (5:00pm ET) on Wednesday, January 5, 2022 to review the Company's priorities and demonstrate its automotive sensor technology. Analysts and investors may pose questions for management during this live webcast on January 5, 2022.
The live webcast and slide presentation, once posted, can be accessed on the Company's Investors webpage under the Events & Presentations tab at https://ir.microvision.com/events-presentations. The webcast will be archived on the website for future viewing.
About MicroVision
MicroVision is a pioneering company in MEMS based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company's integrated approach uses its proprietary technology to provide solutions for automotive lidar sensors, augmented reality micro-display engines, interactive display modules and consumer lidar modules.
For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.
MicroVision is a trademark of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Forward-Looking Statements
Certain statements contained in this release, including the Company's plans regarding product demonstration and product capabilities are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements, including from the impact of COVID-19 (coronavirus); its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor Relations Contact
Jeff Christensen and Matt Kreps
Darrow Associates Investor Relations
MVIS@darrowir.com
SOURCE: MicroVision, Inc.
View source version on accesswire.com:
https://www.accesswire.com/680461/Focused-on-Employee-Health-and-Safety-MicroVision-Shifts-to-All-Virtual-Participation-for-CES-2022
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Continent 8 and FuturePath AI Launch Future8: Accountable AI for Regulated Industries29.9.2026 15:00:00 CEST | Press release
LISBON, PT / ACCESS Newswire / September 29, 2026 / Continent 8 Technologies and FuturePath AI today launched Future8, an AI-native operating company built for regulated operators, formed as a joint venture between the two companies. Announced at SBC Summit Lisbon, Future8 combines FuturePath's enterprise AI applications platform with Continent 8's licensed global operating footprint, enabling the iGaming industry to deploy auditable AI without compromising compliance, data sovereignty and operational control. Built for highly regulated environments, Future8 enables operators to move from AI experimentation to production deployment by embedding governance, approvals and auditability into every workflow from day one. Continent 8 brings licensed data centers and a private global network spanning more than 100 locations, built over 28 years serving the biggest iGaming and online brands, along with AI-enabled Global Capability Centers in India, the Philippines and Bulgaria. The company als
Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release
NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr
Gedeon Richter Launches Online Platform for Transdiagnostic Global Impression Scales and New Caregiver Book at Next Step Conference29.9.2026 14:00:00 CEST | Press release
BUDAPEST, HU / ACCESS Newswire / September 29, 2026 / Gedeon Richter welcomed 145 participants from 27 countries to the latest edition of Next Step, the company's international conference for psychiatrists, held in September at the Hungarian Academy of Sciences. "At Gedeon Richter, we see partnerships as a cornerstone of advancing psychiatric care. By supporting healthcare professionals, patients, and caregivers alike, we can help create meaningful improvements in outcomes, functioning, and quality of life for people living with mental health conditions," said Kristóf Kóczián, Head of Global Business Development and CNS Business Unit at Gedeon Richter in his opening speech. The scientific programme explored how psychiatric care can move beyond diagnostic labels and adopt a more personalized, measurement-based approach. The presentations highlighted how personalized, measurement-based care can be integrated into everyday clinical practice, with a focus on cognitive symptoms, treatment-r
U.S. Polo Assn. Brings 'Game On' to Life with the 2026 Fall-Winter Global Collection29.9.2026 13:00:00 CEST | Press release
WEST PALM BEACH, FL / ACCESS Newswire / September 29, 2026 / U.S. Polo Assn.®, the official sports brand of the United States Polo Association (USPA), has launched its 2026 Fall-Winter Global Collection, a modern expression of American style rooted in the heritage and energy of the sport of polo. Photographed in the beautiful countryside of Millbrook, New York, the campaign blends the sophistication of New York lifestyle with the authenticity of Hudson Valley's equestrian heritage. From local gathering places and small-town Americana to scenic polo fields and countryside settings, the location creates a natural backdrop for ‘Game On,' a seasonal story inspired by campus life, sport, and polo's enduring style. "The 2026 Fall-Winter Global Collection reflects what makes U.S. Polo Assn. distinctive: an authentic connection to the sport, a modern American point of view and style designed for real life," said J. Michael Prince, President and CEO of USPA Global, the company that manages and
Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries29.9.2026 06:45:00 CEST | Press release
ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / Akkodis, a global leader in digital engineering consulting and part of the Adecco Group, and Biolevate, an AI-powered life sciences company, today announced a strategic partnership to accelerate AI-assisted scientific, regulatory and technical documentation in highly regulated industries. Initially launching in France and Belgium, with plans for expansion into additional markets, the partnership combines Biolevate's AI platform with Akkodis' engineering, validation and regulatory expertise to help organizations improve compliance, reduce documentation burdens and accelerate innovation. In highly regulated industries, scientific, technical and compliance-related documentation is critical to product approvals, quality, patient safety and operational compliance. As documentation volumes increase, organizations continue to struggle with manual, resource-intensive processes that are difficult to scale. The result is a pressing nee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
